Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Marketplace

UC Irvine and PDx collaborate, 5/16

May 2016—The Spooner Girls Foundation, which funds research toward treatments and a cure for mitochondrial complex I deficiency, along with the University of California Irvine School of Medicine and Population Diagnostics, announced a collaborative research initiative focused on the NUBPL gene.

Microfluidic system for HIV testing, 5/16

May 2016—Rheonix has completed development and testing of a microfluidic system and assay to simultaneously detect host anti-HIV antibodies and viral RNA in a single specimen of saliva or blood.

Accumen acquires Chi Solutions, 5/16

May 2016—Accumen, a San Diego-based health care services company, has announced the acquisition of Ann Arbor, Mich.-based Chi Solutions, a clinical laboratory consulting and management firm.

RNA fusion reference standards, 5/16

May 2016—The ALK-RET-ROS1 targeted formalin-fixed, paraffin-embedded RNA Fusion Reference Standards from Horizon are a highly characterized, biologically relevant quality control material to assess the performance of next-generation sequencing, RT-PCR, and RT-qPCR assays aimed at detecting gene fusions.

Chromogen for cancer research, 5/16

May 2016—Roche announced the launch of the Discovery Yellow Kit, an alkaline phosphatase-based detection chemistry for tissue diagnostics that produces a unique, transparent yellow signal that is not washed away during alcohol dehydration.

Qiagen,10x Genomics to collaborate, 5/16

May 2016—Qiagen will collaborate with 10x Genomics to develop and promote comprehensive solutions for next-generation sequencing, single-cell biology, and bioinformatics.

CE IVD mark for digital PCR system, 5/16

May 2016—Bio-Rad Laboratories announced CE IVD marking for its QX200 Droplet Digital PCR System. The technology, which partitions a DNA or RNA sample into 20,000 droplets and amplifies targeted sequences within each droplet, allows scientists to precisely detect and quantify low concentrations of target DNA and RNA sequences.

Zika virus detection test, 4/16

April 2016—Euroimmun, headquartered in Luebeck, Germany, has developed a system of comprehensive tests available for the serological detection and differentiation of Zika virus infections.

Telepathology solution, 4/16

April 2016—Mikroscan Technologies released the SL5, a real-time telepathology and whole slide imaging solution for use in anatomic pathology applications.